Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (631-640 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|January 13, 2010
MotavizumabOya Cingoz
Mabs|January 13, 2010
Monoclonal antibodies and other biologic agents in the treatment of asthmaAidan A Long
Mabs|January 13, 2010
GolimumabSohini Mazumdar, David Greenwald
Mabs|January 13, 2010
Industrialization of mAb production technology: the bioprocessing industry at a crossroadsBrian Kelley
Mabs|January 13, 2010
Understanding and circumventing resistance to anticancer monoclonal antibodiesLina Reslan, Stéphane Dalle, Charles Dumontet
Mabs|January 13, 2010
"Inclonals": IgGs and IgG-enzyme fusion proteins produced in an E. coli expression-refolding systemRahely Hakim, Itai Benhar
Mabs|January 13, 2010
Characterization of a chimeric monoclonal antibody against the insulin-like growth factor-I receptorMei-Yun Zhang, Yang Feng, Yanping Wang, et al.
Mabs|January 14, 2010
Inhibitory effects of persistent apoptotic cells on monoclonal antibody production in vitro: simple removal of non-viable cells improves antibody productivity by hybridoma cells in cultureChristopher D Gregory, John D Pound, Andrew Devitt, et al.
Mabs|January 14, 2010
Americas Antibody Congress: September 21-23, 2009, Washington, D.CSusan E Lacy, Christopher J Bond, Dennis Benjamin, et al.
Mabs|January 14, 2010
RaxibacumabSohini Mazumdar
Pageof 184

Showing results (631-640 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|January 13, 2010
MotavizumabOya Cingoz
Mabs|January 13, 2010
Monoclonal antibodies and other biologic agents in the treatment of asthmaAidan A Long
Mabs|January 13, 2010
GolimumabSohini Mazumdar, David Greenwald
Mabs|January 13, 2010
Industrialization of mAb production technology: the bioprocessing industry at a crossroadsBrian Kelley
Mabs|January 13, 2010
Understanding and circumventing resistance to anticancer monoclonal antibodiesLina Reslan, Stéphane Dalle, Charles Dumontet
Mabs|January 13, 2010
"Inclonals": IgGs and IgG-enzyme fusion proteins produced in an E. coli expression-refolding systemRahely Hakim, Itai Benhar
Mabs|January 13, 2010
Characterization of a chimeric monoclonal antibody against the insulin-like growth factor-I receptorMei-Yun Zhang, Yang Feng, Yanping Wang, et al.
Mabs|January 14, 2010
Inhibitory effects of persistent apoptotic cells on monoclonal antibody production in vitro: simple removal of non-viable cells improves antibody productivity by hybridoma cells in cultureChristopher D Gregory, John D Pound, Andrew Devitt, et al.
Mabs|January 14, 2010
Americas Antibody Congress: September 21-23, 2009, Washington, D.CSusan E Lacy, Christopher J Bond, Dennis Benjamin, et al.
Mabs|January 14, 2010
RaxibacumabSohini Mazumdar
Pageof 184